Björn Hackanson
Augsburg University(US)University Hospital Augsburg(DE)
Publications by Year
Research Areas
Acute Myeloid Leukemia Research, Epigenetics and DNA Methylation, Histone Deacetylase Inhibitors Research, Ubiquitin and proteasome pathways, Protein Degradation and Inhibitors
Most-Cited Works
- → Histone deacetylase (HDAC) inhibitors in recent clinical trials for cancer therapy(2010)395 cited
- → Downregulation of Death-Associated Protein Kinase 1 (DAPK1) in Chronic Lymphocytic Leukemia(2007)368 cited
- → Sorafenib promotes graft-versus-leukemia activity in mice and humans through IL-15 production in FLT3-ITD-mutant leukemia cells(2018)284 cited
- → Lymphoid cell growth and transformation are suppressed by a key regulatory element of the gene encoding PU.1(2005)241 cited
- → A multicenter phase II trial of decitabine as first-line treatment for older patients with acute myeloid leukemia judged unfit for induction chemotherapy(2011)230 cited
- → Epigenetic Modification of CCAAT/Enhancer Binding Protein α Expression in Acute Myeloid Leukemia(2008)143 cited